Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Atrolak XL Prolonged-release tablets, all strengths (quetiapine fumarate)

2020-02-12 11:00:41 (10 month(s) ago)

Summary

Accord Healthcare Ltd has informed us that the Patient Information Leaflet (PIL) for all strengths of Atrolak XL Prolonged-release tablets is missing the side effects identified from post-marketing experience.

Read full MHRA article

Respond to this alert